Clinical Trials Browser

Interventional × Metastatic Castrate Resistant Prostate Cancer (mCRPC) × proxalutamide × Clear all

NCT03899467 2024-02-12

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Phase 2 Completed

61 enrolled 12 charts

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT02826772 2020-03-17

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Phase 1 Completed

Metastatic Castrate Resistant Prostate Cancer (mCRPC)